Goldman Sachs

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Retrieved on: 
Wednesday, April 10, 2024

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Key Points: 
  • Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
    Goldman Sachs Asset Management Holdings I B.V. / Goldman Sachs Asset Management Holdings II B.V.
    Goldman Sachs Asset Management Holdings B.V.
    9.
  • In case of proxy voting according to Sec.
  • 34 para.
  • 3 WpHG
    (only in case of attribution of voting rights in accordance with Sec.

Biophytis announces its 2023 financial results and provides an update on its business activities

Retrieved on: 
Wednesday, April 10, 2024

2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.

Key Points: 
  • 2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.
  • Promising preclinical results for BIO101 (20-hydroxyecdysone) in obesity, suggesting beneficial metabolic effects on muscle and fat mass.
  • On this basis, Biophytis plans to start a phase 1/2 clinical trial in 2024, depending on its financial resources.
  • There is therefore significant doubt about the Company's ability to continue its business activities.

EQS-News: Final offer price for DOUGLAS AG shares set at 26.00 euro per share

Retrieved on: 
Wednesday, April 10, 2024

CVC Capital Partners and the Kreke family remain main indirect shareholders after the IPO and do not sell any shares at the IPO.

Key Points: 
  • CVC Capital Partners and the Kreke family remain main indirect shareholders after the IPO and do not sell any shares at the IPO.
  • The total offer size amounts to around 890 million euro with gross proceeds for DOUGLAS AG of around 850 million euro, which corresponds to a market capitalization of DOUGLAS AG of around 2.8 billion euro.
  • Sander van der Laan, CEO DOUGLAS Group, said: “The significant investor interest in the DOUGLAS Group underlines the exceptional work our team has accomplished in recent months.
  • The shares of DOUGLAS AG are expected to be trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange from March 21, 2024, on.

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Retrieved on: 
Wednesday, April 10, 2024

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Key Points: 
  • Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
    Goldman Sachs Asset Management Holdings I B.V. / Goldman Sachs Asset Management Holdings II B.V.
    Goldman Sachs Asset Management Holdings B.V.
    9.
  • In case of proxy voting according to Sec.
  • 34 para.
  • 3 WpHG
    (only in case of attribution of voting rights in accordance with Sec.

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Retrieved on: 
Wednesday, April 10, 2024

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Key Points: 
  • Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
    Goldman Sachs Asset Management Holdings I B.V. / Goldman Sachs Asset Management Holdings II B.V.
    Goldman Sachs Asset Management Holdings B.V.
    9.
  • In case of proxy voting according to Sec.
  • 34 para.
  • 3 WpHG
    (only in case of attribution of voting rights in accordance with Sec.

Biophytis announces its 2023 financial results and provides an update on its business activities

Retrieved on: 
Wednesday, April 10, 2024

2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.

Key Points: 
  • 2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.
  • Promising preclinical results for BIO101 (20-hydroxyecdysone) in obesity, suggesting beneficial metabolic effects on muscle and fat mass.
  • On this basis, Biophytis plans to start a phase 1/2 clinical trial in 2024, depending on its financial resources.
  • There is therefore significant doubt about the Company's ability to continue its business activities.

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Retrieved on: 
Wednesday, April 10, 2024

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Key Points: 
  • Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
    Goldman Sachs Asset Management Holdings I B.V. / Goldman Sachs Asset Management Holdings II B.V.
    Goldman Sachs Asset Management Holdings B.V.
    9.
  • In case of proxy voting according to Sec.
  • 34 para.
  • 3 WpHG
    (only in case of attribution of voting rights in accordance with Sec.

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Retrieved on: 
Wednesday, April 10, 2024

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Key Points: 
  • Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
    Goldman Sachs Asset Management Holdings I B.V. / Goldman Sachs Asset Management Holdings II B.V.
    Goldman Sachs Asset Management Holdings B.V.
    9.
  • In case of proxy voting according to Sec.
  • 34 para.
  • 3 WpHG
    (only in case of attribution of voting rights in accordance with Sec.

EQS-News: CEWE increases dividend for fifteenth consecutive year

Retrieved on: 
Wednesday, April 10, 2024

Oldenburg, 19 March 2024.

Key Points: 
  • Oldenburg, 19 March 2024.
  • The Supervisory Board of CEWE Stiftung & Co. KGaA (SDAX, ISIN: DE 0005403901) decided with its meeting today to propose the fifteenth consecutive dividend increase.
  • CEWE thus further strengthens its position among the top 3 of the 644 listed German companies that have continuously increased their dividends over so many years.
  • : 0441 / 404 - 552, Fax: 0441 / 404 - 421, Email: [email protected]
    The CEWE apps are all available in the app stores: CEWE PHOTO WORLD, CEWE POSTCARD and other photo apps, and the CEWE Investor Relations app for iPad© or android tablets, with annual reports and quarterly reports, presentations and sustainability reports.

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Retrieved on: 
Wednesday, April 10, 2024

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Key Points: 
  • Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
    Goldman Sachs Asset Management Holdings I B.V. / Goldman Sachs Asset Management Holdings II B.V.
    Goldman Sachs Asset Management Holdings B.V.
    9.
  • In case of proxy voting according to Sec.
  • 34 para.
  • 3 WpHG
    (only in case of attribution of voting rights in accordance with Sec.